Immunic, Inc.

Immunic, Inc.verified

IMUX

Price:

$1.05

Market Cap:

$94.58M

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpo...[Read more]

Industry

Biotechnology

IPO Date

2014-04-17

Stock Exchange

NASDAQ

Ticker

IMUX

The PE Ratio as of December 2024 (TTM) for Immunic, Inc. (IMUX) is -0.85

According to Immunic, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.85. This represents a change of -31.10% compared to the average of -1.23 of the last 4 quarters.

Immunic, Inc. (IMUX) Historical PE Ratio (quarterly & annually)

How has IMUX PE Ratio performed in the past?

The mean historical PE Ratio of Immunic, Inc. over the last ten years is -3.71. The current -0.85 PE Ratio has changed 2.19% with respect to the historical average. Over the past ten years (40 quarters), IMUX's PE Ratio was at its highest in in the December 2022 quarter at -0.13. The PE Ratio was at its lowest in in the December 2014 quarter at -10.58.

Quarterly (TTM)
Annual

Average

-3.71

Median

-2.89

Minimum

-12.46

Maximum

-0.19

Immunic, Inc. (IMUX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immunic, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.92%

Maximum Annual PE Ratio = -0.19

Minimum Annual Increase = -95.83%

Minimum Annual PE Ratio = -12.46

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.71145.98%
2022-0.29-88.16%
2021-2.44-55.23%
2020-5.45153.31%
2019-2.151.03%
2018-0.19-95.83%
2017-4.5536.65%
2016-3.33-40.17%
2015-5.57-55.31%
2014-12.465.92%

Immunic, Inc. (IMUX) Average PE Ratio

How has IMUX PE Ratio performed in the past?

The current PE Ratio of Immunic, Inc. (IMUX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.15

5-year avg

-2.21

10-year avg

-3.71

Immunic, Inc. (IMUX) PE Ratio vs. Peers

How is IMUX’s PE Ratio compared to its peers?

Immunic, Inc.’s PE Ratio is less than Generation Bio Co. (-0.49), less than Kronos Bio, Inc. (-0.67), greater than Erasca, Inc. (-4.56), greater than C4 Therapeutics, Inc. (-2.55), greater than Edgewise Therapeutics, Inc. (-22.36), greater than Foghorn Therapeutics Inc. (-3.45), less than Shattuck Labs, Inc. (-0.76), greater than Monte Rosa Therapeutics, Inc. (-4.84), greater than Kymera Therapeutics, Inc. (-18.55), greater than Nurix Therapeutics, Inc. (-8.05), less than Kezar Life Sciences, Inc. (0), greater than Spruce Biosciences, Inc. (-5.00), less than Eyenovia, Inc. (-0.41), less than null (-0.16),

Build a custom stock screener for Immunic, Inc. (IMUX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunic, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunic, Inc. (IMUX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Immunic, Inc.'s PE Ratio?

How is the PE Ratio calculated for Immunic, Inc. (IMUX)?

What is the highest PE Ratio for Immunic, Inc. (IMUX)?

What is the 3-year average PE Ratio for Immunic, Inc. (IMUX)?

What is the 5-year average PE Ratio for Immunic, Inc. (IMUX)?

How does the current PE Ratio for Immunic, Inc. (IMUX) compare to its historical average?